Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital

Journal Title: Oman Medical Journal - Year 2019, Vol 34, Issue 5

Abstract

Objectives: Breast cancer (BC) is the leading cancer among women. Almost 20% of patients develop brain metastases (BM) and die shortly afterward. There is a dearth of data on the survival outcome of BC patients with BM from the Arab world. Methods: Consecutive women diagnosed with BC who developed radiologically-confirmed BM during their illness were identified through the hospital’s electronic patient’s records. Clinicopathological features and treatment outcomes were recorded. Survival was calculated using the Kaplan-Meier method, and factors affecting survival were studied using log-rank analysis. Results: Between January 2003 and June 2015, a total of 692 patients were treated for BC at our institute. Forty-eight (6.9%) developed BM. The median age at the diagnosis of BM was 45.2 years. More than half of cohort (54.2%) had HER2 positive disease, while 27.1% had the triple-negative disease. The median time interval between the diagnosis of BC and the development of BM was 21 months, and median survival after development of brain disease was seven months. On univariate analysis, pathological grade, previous systemic treatment, brain as the first site of metastases, brain as the only site of metastases, treatment of BM, systemic treatment after BM, and diagnosis-specific graded prognostic assessment (DS-GPA) score significantly affected survival. On multivariate Cox regression analysis, the brain as the first site of metastases, treatment for brain disease, treatment type, and DS-GPA score significantly affected survival post-BM. Conclusions: Our data indicate that Omani women are diagnosed with BC at a younger age, develop BM earlier, and carry a poor outcome.

Authors and Affiliations

Khawaja F. Zahid, Shiyam Kumar, Khalid Al-Bimani, Tanweer Ahmed, Adil Al-Ajmi, Ikram A. Burney, Mansour Al-Moundhri

Keywords

Related Articles

Depression: Prevalence and Associated Risk Factors in the United Arab Emirates

Depression is a prevalent mental healthcare problem and a common cause of disability worldwide. The purpose of this study was to determine the prevalence and risk factors of depression in individuals living in the UAE. W...

Trends and Histopathological Patterns of Kaposi Sarcoma at The University of Benin Teaching Hospital, Benin City, Nigeria

Objectives: Kaposi sarcoma (KS) shows greater geographic variation in incidence than almost any other vascular tumor globally. KS is common in parts of Sub-Saharan Africa accounting for 9% of all diagnosed cancer cases i...

Pertussis and Pertussis like Illness: Pediatric Experience in Oman

Objectives: A resurgence of pertussis or whooping cough has been observed worldwide despite broad vaccination coverage. Pertussis like illness (PLI) refers to a clinical syndrome compatible with pertussis infection but l...

Prevalence of Nephrotoxicity in HIV Patients Treated with Tenofovir Disoproxil Fumarate: A Single-center Observational Study

Objectives: Tenofovir disoproxil fumarate (TDF) has been reported to cause nephrotoxicity necessitating cessation in some patients. No information is available on the nephrotoxic effect of TDF in Omani or regional patien...

Gestation-wise Reference Ranges of Neutrophil Counts in Indian Newborns

Objectives: Blood counts are commonly performed tests in neonatal intensive care units with the results having various clinical ramifications. Interpreting blood counts as normal or abnormal requires reference ranges as...

Download PDF file
  • EP ID EP634686
  • DOI 10.5001/omj.2019.76
  • Views 78
  • Downloads 0

How To Cite

Khawaja F. Zahid, Shiyam Kumar, Khalid Al-Bimani, Tanweer Ahmed, Adil Al-Ajmi, Ikram A. Burney, Mansour Al-Moundhri (2019). Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital. Oman Medical Journal, 34(5), 412-419. https://europub.co.uk./articles/-A-634686